Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESCUE: A Randomized, Blinded, Placebo-controlled, Parallel Group Design to Determine the Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy

NCT04693715 is registered in ClinicalTrials.gov with Revalesio Corporation as lead sponsor.

NCT NCT04693715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04693715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESCUE: A Randomized, Blinded, Placebo-controlled, Parallel Group Design to Determine the Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy
Lead sponsor
Revalesio Corporation
Phase
Phase 2
Overall status
Completed
Start date
July 7, 2021
Completion date
November 8, 2023
Enrollment
83 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, ischemic